Price History

Hover for the daily close. The dotted line marks the period open.

Compare FEMY with… →

FEMY Key Statistics

As of Sep 4, 2026

Trading

Open: $3.03
Previous Close: $3.06
Day's Range: 2.93–3.06
52-Week Range: 2.02–22.20
Volume: 72.90K
Beta: −2.07

Valuation

Market Cap: $24.96M
P/E Ratio: unprofitable
P/S ratio: 10.85
EPS (ttm): −2.66

Financials (FY)

Revenue (FY): $2.29M+40.77%
Net Income (FY): −$18.63M
Profit margin: 0.00%
Shares Outstanding: 8.38M
1-Year Return: −59.51%

Dividend and dates

Avg Volume: 731.89K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

FEMY Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−67.50%−76.92%+8.33%+12.82%−47.64%−74.13%

2021*20222023202420252026*

Year	Return
2026 (partial year)	−74.13%
2025	−47.64%
2024	+12.82%
2023	+8.33%
2022	−76.92%
2021 (partial year)	−67.50%

As of September 4, 2026.

FEMY Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$2.29M	−$18.63M	−812.3%
2024	$1.63M	−$18.82M	−1155.0%
2023	$1.07M	−$14.25M	−1329.1%
2022	$1.21M	−$11.39M	−944.6%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$2.29M	$1.42M	−$17.59M	−$18.63M	−812.3%
2024	$1.63M	$1.08M	−$17.79M	−$18.82M	−1155.0%
2023	$1.07M	$691.90K	−$14.51M	−$14.25M	−1329.1%
2022	$1.21M	$764.28K	−$11.60M	−$11.39M	−944.6%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

FEMY Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks

Metric	FEMY	Medical Instruments & Supplies median	vs median
P/S ratio	10.85	3.17	3.4x the median
Profit margin	0.00%	0.85%	0.8 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Femasys Inc. (FEMY) is capitalised at $24.96M on the latest close. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. Headcount on file is 51.

The most recent close on file for FEMY is $2.98, dated September 4, 2026. That is −$0.08 (−2.61%) against the previous close. Over the past 52 weeks the price has ranged from $2.02 to $22.20. The latest close sits 47.38% above that 52-week low.

Financial Health

In fiscal 2025, Femasys Inc. reported revenue of $2.29M. That is +40.77% against the prior fiscal year, when revenue was $1.63M. The same year closed with a net loss of $18.63M. The reported profit margin is 0%. That is 0.8 percentage points below the Medical Instruments & Supplies median of 0.85%. Trailing earnings per share are −2.66.

Across the 4 fiscal years on file, revenue moves from $1.21M in 2022 to $2.29M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 10.85 times revenue. On price-to-sales that is 3.4 times the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

The trailing one-year price return is −59.51%. Measured over 5 years, that is −54.12% a year compounded. Beta against the wider market is reported at −2.07. Daily returns over the trailing 5 years annualize to a volatility of 204.61%.

Growth & Income

No dividend is on file for FEMY.

2026 is still running; the price is −74.13% year to date. The strongest complete calendar year on file is 2024 at +12.82%; the weakest is 2022 at −76.92%. Of the 4 complete calendar years on file, 2 finished higher.

Peer Comparison

Femasys Inc. (FEMY) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Femasys Inc.	FEMY	$24.96M	—
Intuitive Surgical, Inc.	ISRG	$131.38B	42.4
Becton, Dickinson and Company	BDX	$50.32B	32.0
Medline Inc.	MDLN	$49.23B	45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Femasys Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

BDX

Becton, Dickinson and Company

$50.32B

MDLN

Medline Inc.

$49.23B

ALC

Alcon Inc.

$34.08B

RMD

ResMed Inc.

$32.94B

WST

West Pharmaceutical Services, Inc.

$23.93B

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Femasys Inc.

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Visit website →

Femasys Inc. (FEMY) Stock Analysis